Literature DB >> 28139249

Interventions to Improve Pharmacological Adherence Among Adults With Psychotic Spectrum Disorders and Bipolar Disorder: A Systematic Review.

Daniel Hartung1, Allison Low2, Kazuaki Jindai3, David Mansoor3, Matthew Judge3, Aaron Mendelson4, Devan Kansagara5, Makalapua Motu Apuaka2, Michele Freeman6, Karli Kondo7.   

Abstract

BACKGROUND: It is unclear as to which interventions are effective at improving medication adherence in individuals with serious and persistent mental illness. The goal of this systematic review is to synthesize evidence examining the effectiveness, harms, and costs of interventions to improve medication adherence in patients with psychotic spectrum disorders and bipolar disorder.
METHODS: We conducted a systematic search of several electronic databases through January 2015 using a structured search strategy. Studies were included if they involved adult patients in general mental health settings, reported both measures of medication adherence and clinical outcomes, and were of sufficient methodological rigor. Studies were quality assessed and synthesized using established methods.
RESULTS: We identified 24 studies that met inclusion criteria. Overall, 20 studies addressed interventions in patients with psychotic spectrum disorders. These interventions varied widely, with generally mixed findings contributing to low or insufficient strength of evidence; studies involving family members and technology interventions were the most consistently associated with a positive effect; however, the strength of the evidence was low because of intervention heterogeneity. The evidence was insufficient to determine the effectiveness of interventions in patients with bipolar disorder.
CONCLUSIONS: In individuals with psychotic spectrum disorders, interventions with family members or technology had the most consistent positive effect on adherence, although replication with objective adherence measures along with evaluation of harms and costs is needed. There was insufficient evidence to draw conclusions about interventions in individuals with bipolar disorder.
Copyright © 2017 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bipolar disorder; medication adherence; pharmacotherapy; schizophrenia.

Mesh:

Substances:

Year:  2016        PMID: 28139249     DOI: 10.1016/j.psym.2016.09.009

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

1.  Self-Report for Measuring and Predicting Medication Adherence: Experts' Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics.

Authors:  Carlos De Las Cuevas; Jose de Leon
Journal:  Patient Prefer Adherence       Date:  2020-10-09       Impact factor: 2.711

2.  Bridging the gap between physical and mental illness in community pharmacy (PharMIbridge): protocol for an Australian cluster randomised controlled trial.

Authors:  Amanda J Wheeler; Claire L O'Reilly; Sarira El-Den; Joshua Byrnes; Robert S Ware; Sara S McMillan
Journal:  BMJ Open       Date:  2020-07-23       Impact factor: 2.692

3.  Mental healthcare users' self-reported medication adherence and their perception of the nursing presence of registered nurses in primary healthcare.

Authors:  Lillian Kalimashe; Emmerentia du Plessis
Journal:  Health SA       Date:  2021-07-22

4.  A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.

Authors:  Jennifer B Levin; Farren Briggs; Carol Blixen; Mark Bauer; Douglas Einstadter; Jeffrey M Albert; Celeste Weise; Nicole Woods; Edna Fuentes-Casiano; Kristin A Cassidy; Julie Rentsch; Kaylee Sarna; Martha Sajatovic
Journal:  Trials       Date:  2022-08-04       Impact factor: 2.728

5.  A WeChat-based self-compassion training to improve the treatment adherence of patients with schizophrenia in China: Protocol for a randomized controlled trial.

Authors:  Die Dong; Ting-Yu Mu; Jia-Yi Xu; Jia-Ning Dai; Zhi-Nan Zhou; Qiong-Zhi Zhang; Cui-Zhen Shen
Journal:  Front Psychol       Date:  2022-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.